microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR

miR-137 inhibits proliferation of melanoma cells by targeting PAK2

(2015) Shuai Hao et al.   EXPERIMENTAL DERMATOLOGY

Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer

(2015) Nahyeon Kang et al.   LUNG CANCER

MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells

(2015) Veronica Kalhori et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis

(2015) Jong-Min Lee et al.   Oncotarget

Sphingosine-1-Phosphate Induces the Migration of Thyroid Follicular Carcinoma Cells through the MicroRNA-17/PTK6/ERK1/2 Pathway

(2015) Shitao Zhao et al.   PLoS One

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2

(2015) Li-Li Liu et al.   Oncotarget

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation

(2014) Xiushan Zheng et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3

(2014) Youcheng Xiu et al.   PLoS One

Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK–Mediated Up-Regulation of MMP-2 and MMP-9

(2013) Qian-ze Dong et al.   AMERICAN JOURNAL OF PATHOLOGY

miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1

(2013) Jinling Guo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Expression of activator protein-1 (AP-1) family members in breast cancer

(2013) Amirhossein Kharman-Biz et al.   BMC CANCER

Overexpressed miRNA-137 Inhibits Human Glioma Cells Growth by Targeting Rac1

(2013) Guan Sun et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A

(2013) Kristina Althoff et al.   INTERNATIONAL JOURNAL OF CANCER

Relationship between Protein Expression of VEGF-C, MMP-2 and Lymph Node Metastasis in Papillary Thyroid Cancer

(2013) X Tian et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Comprehensive MicroRNA Expression Profiling Identifies Novel Markers in Follicular Variant of Papillary Thyroid Carcinoma

(2013) Matthias Dettmer et al.   THYROID

miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin

(2013) Yueyang Bi et al.   Human Cell

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6

(2012) Xiaolan Zhu et al.   FEBS LETTERS

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

(2011) M. K. Gule et al.   CLINICAL CANCER RESEARCH

miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42

(2011) Qingjiang Chen et al.   DIGESTIVE DISEASES AND SCIENCES

Thyroid Cancer Epidemiology and Prognostic Variables

(2010) J.A. Sipos et al.   CLINICAL ONCOLOGY

miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells

(2010) Ming Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Association of EGFR and HER2 Polymorphisms with Risk and Clinical Features of Thyroid Cancer

(2009) Maha Rebaï et al.   Genetic Testing and Molecular Biomarkers

Biomarker panel diagnosis of thyroid cancer: a critical review

(2008) Obi L Griffith et al.   Expert Review of Anticancer Therapy